Edition:
United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

4,310JPY
21 Aug 2017
Change (% chg)

-- (--)
Prev Close
¥4,310
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
905,073
52-wk High
¥4,735
52-wk Low
¥3,010

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 29.60 December 21 Aug 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 5 5 5 5
(3) HOLD 5 4 4 4
(4) UNDERPERFORM 0 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.15 2.23 2.23 2.23

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 5 128,610.00 134,200.00 123,700.00 --
Quarter Ending Dec-17 5 143,921.00 150,781.00 139,600.00 --
Year Ending Dec-17 13 522,956.00 534,105.00 516,600.00 531,070.00
Year Ending Dec-18 13 548,923.00 567,023.00 539,000.00 560,973.00
Earnings (per share)
Quarter Ending Sep-17 4 29.60 33.80 24.93 --
Quarter Ending Dec-17 4 31.66 37.70 27.00 --
Year Ending Dec-17 14 125.73 139.80 119.59 121.12
Year Ending Dec-18 14 135.96 157.43 123.20 140.68
LT Growth Rate (%) 3 16.54 19.00 13.30 6.10

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 127,403.00 127,307.00 96.00 0.08
Quarter Ending Mar-17 119,692.00 125,467.00 5,775.00 4.82
Quarter Ending Dec-16 126,146.00 130,263.00 4,117.40 3.26
Quarter Ending Sep-16 122,178.00 113,986.00 8,192.25 6.71
Quarter Ending Jun-16 124,678.00 127,638.00 2,959.50 2.37

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 128,610.00 128,610.00 128,450.00 129,983.00 --
Quarter Ending Dec-17 143,921.00 143,921.00 142,419.00 140,238.00 --
Year Ending Dec-17 522,956.00 522,956.00 522,980.00 522,796.00 531,070.00
Year Ending Dec-18 548,923.00 548,923.00 547,836.00 546,986.00 560,973.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 2 1
Quarter Ending Dec-17 0 0 4 0
Year Ending Dec-17 0 0 6 1
Year Ending Dec-18 0 0 5 3
Earnings